IDiyas

For the Inventor, By the Inventor

Weinheim, Germany

Gerda Von Philipsborn

USPTO Granted Patents = 20

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 98(Granted Patents)


Company Filing History:

goldMedal19 out of 10,754 
 
Basf Aktiengesellschaft
 patents
silverMedal1 out of 84 
 
Knoll Aktiengesellschaft
 patents

Years Active: 1980-1993

Loading Chart...
20 patents (USPTO):
1. 5270325 - P-hydroxy phenone derivatives used in the treatment of cardiac arrhythmia (1993-12-14),
2. 5260330 - Substituted anilides (1993-11-09),
3. 5214047 - Tetracyclic quinazoline derivatives, effective as antiarrythmic agents (1993-05-25),
4. 5118685 - Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, and (1992-06-02),
5. 5118682 - p-Hydroxy phenone derivatives and the use thereof (1992-06-02),
6. 5055475 - P-hydroxy phenone derivatives and drugs containing these (1991-10-08),
7. 4980361 - P-hydroxy phenone derivatives and drugs containing these (1990-12-25),
8. 4959373 - Bispidine derivatives as class III antiarrhythmic agents (1990-09-25),
9. 4958046 - Hydroxypropafenone glycerides (1990-09-18),
10. 4945114 - Therapeutic agents containing enantiomers of propafenone (1990-07-31),
11. 4730042 - Compounds 1 or (1988-03-08),
12. 4571409 - Aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones, (1986-02-18),
13. 4556662 - Bispidine derivatives and antiarrhythmic compositions (1985-12-03),
14. 4540697 - Aminopropanol derivatives of 2-hydroxy-.beta.-phenyl-propiophenones, (1985-09-10),
15. 4459301 - Method of treating cardiac disorders using bispidine derivatives (1984-07-10),

Title: Gerda von Philipsborn: A Pioneer in Cardiac Pharmacology

Introduction

Gerda von Philipsborn, an accomplished inventor based in Weinheim, Germany, has made significant contributions to the field of cardiac pharmacology. With a remarkable portfolio of 20 patents, her work has advanced the understanding and treatment of cardiac arrhythmia, contributing to better health outcomes for patients globally.

Latest Patents

Among her latest innovations are the development of p-hydroxy phenone derivatives specifically used in the treatment of cardiac arrhythmia. These derivatives, formulated under the specific conditions outlined in her patents, represent a crucial advancement in therapeutic strategies. Additionally, she has created substituted anilides that provide alternatives for various applications, highlighting her dedication to advancing medical treatment options.

Career Highlights

Throughout her illustrious career, Gerda has worked with well-known chemical companies, including BASF Aktiengesellschaft and Knoll Aktiengesellschaft. Her contributions at these organizations have helped drive innovation and strengthen their portfolios in pharmaceuticals. Her work is characterized by rigorous research and groundbreaking discoveries that have gained recognition within the scientific community.

Collaborations

Gerda has collaborated with esteemed colleagues such as Dieter Lenke and Claus D. Mueller, emphasizing the importance of teamwork in driving innovation. These partnerships have fostered a collaborative environment where knowledge and expertise can be shared, leading to significant advancements in their respective fields.

Conclusion

Gerda von Philipsborn is a trailblazer in the realm of cardiac pharmacology, with a wealth of experience reflected in her numerous patents and collaborations. Her innovative approaches continue to pave the way for advancements in medical treatment, underscoring the vital role of inventors in improving healthcare and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…